A doctor wearing a hazmat suit pictured administering a vaccine for a patient in Depok, Indonesia. Photo: EPAA doctor wearing a hazmat suit pictured administering a vaccine for a patient in Depok, Indonesia. Photo: EPA
A doctor wearing a hazmat suit pictured administering a vaccine for a patient in Depok, Indonesia. Photo: EPA
Muhammad Zulfikar Rakhmat
Opinion

Opinion

Muhammad Zulfikar Rakhmat

Indonesia’s Sinovac coronavirus vaccine trial raises safety, affordability concerns

  • President Joko Widodo’s demand for a vaccine to be available within months has sparked fears the country is rushing ahead without proper precautions
  • There are also concerns over cost and availability should the trials prove successful and whether ordinary Indonesians are being used as ‘human guinea pigs’

A doctor wearing a hazmat suit pictured administering a vaccine for a patient in Depok, Indonesia. Photo: EPAA doctor wearing a hazmat suit pictured administering a vaccine for a patient in Depok, Indonesia. Photo: EPA
A doctor wearing a hazmat suit pictured administering a vaccine for a patient in Depok, Indonesia. Photo: EPA
READ FULL ARTICLE
Close
We need your support

Advertising helps us continue to provide quality content. Help support us by disabling your adblocker on our site.

How to whitelist us:
  1. 1
    Click on the AdBlock icon at the top right corner of your browser.
    For iOS, go to Settings/Safari/Content Blockers and turn it off.

    For Android, go to your Ad blocker app/Settings and turn it off.
  2. 2
    Click Enabled on this site until the text reads Disabled on this site.
  3. 2
    Click the cross icon on the top right corner to close this window and refresh the page.
  4. 3
    Click the cross icon on the top right corner to close this window and refresh the page.